Form 4: Tourmaline Bio Executive Acquires Stock Options
SEC Form 4 Filing
W. Bradford Middlekauff, CBO, GC and Secretary of Tourmaline Bio, Inc., reports the acquisition of employee stock options.
Summary
- On January 27, 2025, W. Bradford Middlekauff, CBO, GC and Secretary of Tourmaline Bio, Inc., acquired 58,000 employee stock options.
- The exercise price of these options is $17.
- The options vest as to 25% on January 27, 2026, and the remaining 75% vest in 36 equal monthly installments, contingent upon continued service.
- The expiration date for these options is January 26, 2035.
- Following the transaction, Middlekauff directly owns 58,000 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by an executive generally reflects confidence in the company's future, but it's a routine transaction.
Positives
- The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting schedule indicates a long-term incentive plan for the executive, aligning their interests with the company's performance over the coming years.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the executive's participation in the company's equity compensation plan.
Key Dates
| Date | Description |
|---|---|
| 01/27/2025 | Date of the transaction: acquisition of employee stock options. |
| 01/27/2026 | Date when 25% of the acquired stock options vest. |
| 01/26/2035 | Expiration date of the acquired stock options. |
| 01/29/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.